Carla Chaney Biography and Net Worth

Carla joined Equifax as Chief Human Resources Officer in 2019, reporting directly to the CEO. In this role, Carla has global accountability for the Human Resources function, focusing on attracting, retaining, and developing our people while evolving our culture.

A broad, global HR leader, Carla joined us from Graphic Packaging International where she served as Executive Vice President, Human Resources & Communications, with a significant portion of her role focused on building and developing talent to ensure the company’s profitable growth agenda was realized. During her tenure at Graphic Packaging, the company successfully transformed their portfolio through acquisitions and innovation, moving into a global packaging leadership position. Prior to Graphic Packaging, Carla held U.S.-and international-based executive roles at Exide Technologies, Newell Rubbermaid, and Georgia Pacific.

Carla is a New York state native and earned her bachelor’s degree in Industrial and Labor Relations from Cornell University. She also completed the Chief Human Resources Officer Development program at Cornell. Carla currently sits on the Women’s Leadership Center Advisory Board at the Kennesaw State University College of Business, and is a Board member for the Community Assistance Center in Sandy Springs which focuses on enabling those in need to find their way to self-sufficiency.

What is Carla Chaney's net worth?: The estimated net worth of Carla Chaney is at least $3.20 million as of May 24th, 2023. Ms. Chaney owns 14,308 shares of Equifax stock worth more than $3,196,693 as of April 27th. This net worth estimate does not reflect any other assets that Ms. Chaney may own. Learn More about Carla Chaney's net worth.
How do I contact Carla Chaney?: The corporate mailing address for Ms. Chaney and other Equifax executives is 1550 PEACHTREE STREET N.W., ATLANTA GA, 30309. Equifax can also be reached via phone at (404) 885-8000 and via email at [email protected]. Learn More on Carla Chaney's contact information.
Has Carla Chaney been buying or selling shares of Equifax?: Carla Chaney has not been actively trading shares of Equifax during the last quarter. Most recently, Carla Chaney sold 15,180 shares of the business's stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $207.54, for a transaction totalling $3,150,457.20. Following the completion of the sale, the executive vice president now directly owns 14,308 shares of the company's stock, valued at $2,969,482.32. Learn More on Carla Chaney's trading history.
Who are Equifax's active insiders?: Equifax's insider roster includes Mark Begor (CEO), Carla Chaney (EVP), Prasanna Dhore (Insider), John Gamble (CFO), James Griggs (SVP), Julia Houston (EVP), Julia Houston (EVP), John Kelley (Insider), Bryson Koehler (CTO), Lisa Nelson (EVP), and Sid Singh (Insider). Learn More on Equifax's active insiders.
Are insiders buying or selling shares of Equifax?: During the last twelve months, Equifax insiders bought shares 1 times. They purchased a total of 914 shares worth more than $151,970.78. During the last twelve months, insiders at the credit services provider sold shares 9 times. They sold a total of 55,680 shares worth more than $11,138,674.70. The most recent insider tranaction occured on November, 1st when CEO Mark W Begor sold 7,000 shares worth more than $1,166,060.00. Insiders at Equifax own 1.6% of the company. Learn More about insider trades at Equifax.
Information on this page was last updated on 11/1/2023.

Carla Chaney Insider Trading History at Equifax

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/24/2023	Sell	15,180	$207.54	$3,150,457.20	14,308

Carla Chaney Buying and Selling Activity at Equifax

Equifax Company Overview

Equifax Inc. operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship. The USIS segment provides consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting services; mortgage services; financial marketing services; identity management services; and credit monitoring products. The International segment offers information service products, which include consumer and commercial services, such as credit and financial information, and credit scoring and modeling; and credit and other marketing products and services, as well as offers information, technology, and other services to support debt collections and recovery management. The company serves customers in financial services, mortgage, retail, telecommunications, utilities, automotive, brokerage, healthcare, and insurance industries, as well as government agencies. It operates in Argentina, Australia, Brazil, Canada, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Honduras, India, Ireland, Mexico, New Zealand, Paraguay, Peru, Portugal, Spain, the United Kingdom, Uruguay, and the United States. The company was founded in 1899 and is headquartered in Atlanta, Georgia.

Today's Range

Now: $223.42

$223.20

$227.90

50 Day Range

MA: $254.71

$216.20

$273.59

2 Week Range

Now: $223.42

$159.95

$275.10

Volume

850,314 shs

Average Volume

868,978 shs

Market Capitalization

$27.62 billion

P/E Ratio

49.76

Dividend Yield

0.69%

Beta

1.51

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>